Seattle Genetics plans to hire 200 employees and seek Food and Drug Administration approval of another application for its flagship drug.
Seattle Genetics CEO Clay Siegall plans to add the employees by the end of the year, he told a group of Seattle-area brokers, analysts and portfolio managers Thursday.
The company hired nearly 150 people in 2016 and more than 100 the year before.
Based on December results of a skin cancer drug trial, Siegall said the company will soon apply for FDA approval…
Seattle Genetics plans to hire 200 employees and seek Food and Drug Administration approval of another application for its flagship drug.
Seattle Genetics CEO Clay Siegall plans to add the employees by the end of the year, he told a group of Seattle-area brokers, analysts and portfolio managers Thursday.
The company hired nearly 150 people in 2016 and more than 100 the year before.
Based on December results of a skin cancer drug trial, Siegall said the company will soon apply for FDA approval…